Zila to market ViziLite Plus in Russia

Zila has selected DentalMed Russian Alliance to be the exclusive distributor of ViziLite Plus with TBlue in Russia and Belarus. ViziLite Plus with TBlue is an FDA-approved medical device for the early detection of oral cancer.

"The marketing of ViziLite Plus in Russia and Belarus represents a solid step in our plan to provide this lifesaving product outside the U.S.," stated David Bethune, chairman and CEO of Zila, in a press release. "DentalMed has ties to the Russian National Institute of Adaptation of Marketing Strategies and has broad experience launching professional dental products in Russia."

Page 1 of 40
Next Page